Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000409370) titled 'Safety and Feasibility of Using the Omnipod M AID System with a Novel Combination of Insulin in Adults with Type 2 Diabetes' on April 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Other
Primary Sponsor: Edge Trials Limited
Condition:
Type 2 diabetes
Type 2 diabetes
Metabolic and Endocrine - Diabetes
Intervention:
This is a multi-arm, non-randomised feasibility study with two participant cohorts.
Cohort A: EVOLUTION 2 participants and new T2D participants who have used the Omnipod M System configured for U-100...